[Effect of a new pharmaceutical form of fenigidin on the coronary circulation and left ventricular contractility in dogs with acute myocardial infarction].
The experiments on dogs with acute myocardial infarction have revealed that fenigidine, a new pharmaceutical form of calcium antagonist, does not provoke a deterioration of the left ventricular function, but normalizes it. The coronary blood flow greatly increases under the influence of remedy (more than 3 hours).
Mokhort
M A
MA
Seredynska
N M
NM
Tytov
M Iu
MIu
D000818:Animals; D003326:Coronary Circulation / Q000187:drug effects*; D004285:Dogs; D005260:Female; D008297:Male; D009200:Myocardial Contraction / Q000187:drug effects*; D009203:Myocardial Infarction / Q000188:drug therapy*; D009543:Nifedipine / Q000494:pharmacology* / Q000627:therapeutic use*; D013268:Stimulation, Chemical; D016277:Ventricular Function, Left / Q000187:drug effects*
D009543:Nifedipine